A vertically integrated oncology-first healthcare platform in Spanish-speaking Latin America, priced for Mexico/Colombia risk but levered to a turnaround-driven re-rating.
Overview
Auna S.A. is a specialized, oncology-forward healthcare platform serving Spanish-speaking Latin America—primarily Peru, Mexico, and Colombia—built around a distinctive integrated model (“AunaWay”) that links insurance/health plans with a regional network of high-complexity hospitals, clinics, and outpatient centers. The company, founded in 1989 and listed on the NYSE in March 2024, operates 31 facilities (≈2,333 beds) and manages a growing base of ~1.4 million plan members. Its model is designed to solve structural gaps in public systems by offering predictable financing (through plans like Peru’s Oncosalud) and high-end clinical outcomes in areas such as oncology, which represents the largest share of healthcare spending in the region. In 2025, Auna entered a pivotal “stabilization” phase: Peru and Colombia supported results while Mexico underperformed due to operational frictions, yet the company improved earnings quality via stronger cash flow, record-low oncology MLR (48.5%), and major refinancing—setting the stage for a potential re-acceleration if Mexico volumes and utilization recover.